Anders Svenningsson
Danderyd, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.
Journal: Annals of clinical and translational neurology
Published: December 19, 2025
Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay.
Journal: Scientific reports
Published: December 18, 2025
Increased susceptibility and volume reduction in deep brain nuclei in primary orthostatic tremor.
Journal: BMJ neurology open
Published: December 15, 2025
Immunoglobulin-G dynamics and relation to antibiotic prescriptions in multiple sclerosis patients treated with rituximab: a real-world cohort.
Journal: Multiple sclerosis and related disorders
Published: November 30, 2025
Clinical Characteristics of Primary Orthostatic Tremor - a Comprehensive Clinical Assessment of Patients in Sweden.
Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
Published: November 29, 2025
Letter Concerning Comparative Safety Profiles of Ocrelizumab and Rituximab in MS Treatment.
Journal: Annals of neurology
Published: November 14, 2025
Orthostatic Tremor Is Evoked by Muscle Load Without the Need for Orthostatic Position.
Journal: Movement disorders clinical practice
Published: May 20, 2025
The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: March 20, 2025
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab.
Journal: Multiple sclerosis and related disorders
Published: February 23, 2025
Cortical response to proprioceptive stimulation in primary orthostatic tremor - a magnetoencephalography study.
Journal: Clinical neurophysiology practice
Published: January 15, 2025
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.
Journal: Annals of neurology
Published: February 20, 2024
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.
Journal: European journal of neurology
Published: January 30, 2024
Last Updated: 09/26/2026